California Proposing $429 Million For Stem Cell and Gene Therapy Research; Almost Certain to be Approved

Funding isolated from Trump administration cuts, no state legislative approval needed

Patient advocate Kim Nye addressed the CIRM board last year, seeking funding for rare disease research.

Following nearly a month of chaos on the federal research funding scene, California’s stem cell and gene therapy agency takes up a $429 million plan this Wednesday to ferret out treatments for afflictions ranging from cancer to Alzheimer’s disease.

The…